Galt buy adds to Theragenics' surgical business
This article was originally published in Clinica
In a move to flesh out its surgical products division, Theragenics has acquired Galt Medical, a private developer of disposable, vascular access products in a $31.9m cash-and-stock transaction.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.